Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1324-1330

  Liu, Ya ^a   Zhang, Hai Gang ^a   Jia, Yi ^a   Li, Xiao Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Inflammation; Monocyte chemoattractant protein 1; Nuclear transcription factor b; Panax notoginseng saponin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GINSENG SAPONIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PANAX NOTOGINSENG SAPONIN; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA ATHEROSCLEROSIS; AORTA WALL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; LIPID DIET; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA, THORACIC; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LIPIDS; MALE; MEDICINE, CHINESE TRADITIONAL; NF-KAPPA B; PANAX NOTOGINSENG; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; ZYMOSAN;

EID: 77956098022     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1324     Document Type: Article

References (63)

1. Ross R., Nature (London), 362, 801-809 (1993).
2. Paoletti R., Gotto A. M. Jr., Hajjar D. P., Circulation, 109, III20-III26 (2004).
3. Castelli W. P., Atherosclerosis, 124, S1-S9 (1996).
4. Stampfer M. J., Malinow M. R., N. Engl. J. Med., 332, 328-329 (1995).
5. Superko H. R., Chronos N. A., Curr. Treat. Options Cardiovasc. Med., 5, 35-50 (2003).
6. Packard R. R., Libby P., Clin. Chem., 54, 24-38 (2008).
7. Gabriel S. E., Crowson C. S., Kremers H. M., Doran M. F., Turesson C., O'Fallon W. M., Matteson E. L., Arthritis Rheum., 48, 54-58 (2003).
8. Doria A., Iaccarino L., Ghirardello A., Zampieri S., Arienti S., Sarzi-Puttini P., Atzeni F., Piccoli A., Todesco S., Am. J. Med., 119, 700-706 (2006).
9. Solomon D. H., Karlson E. W., Rimm E. B., Cannuscio C. C., Mandl L. A., Manson J. E., Stampfer M. J., Curhan G. C., Circulation, 107, 1303-1307 (2003).
10. Fischer L. M., Schlienger R. G., Matter C., Jick H., Meier C. R., Am. J. Cardiol., 93, 198-200 (2004).
11. Turesson C., McClelland R. L., Christianson T. J., Matteson E. L., Ann. Rheum. Dis., 66, 70-75 (2007).
12. Lusis A. J., Nature (London), 407, 233-241 (2000).
13. Shashkin P., Dragulev B., Ley K., Curr. Pharm. Res., 11, 3061-3072 (2005).
14. Taubes G., Science, 296, 242-245 (2002).
15. Cicero A. F. G., Bandieri E., Arletti R., J. Ethnopharmacol., 73, 387-391 (2000).
16. Huang Y. S., Yang Z. C., Yan B. G., Hu X. C., Li A. N., Crowther R. S., Burns, 25, 35-41 (1999).
17. Xuejiang W., Ichikawa H., Konishi T., Biol. Pharm. Bull., 24, 558-563 (2001).
18. Li X. H., Li S. H., Chin. Tradit. Herb. Drugs, 307, 514-515 (1999).
19. Liu S., Chen J. X., Acta Pharmacol. Sin., 5, 100-103 (1984).
20. Liu Y., Li X. H., Chin. Tradit. Herb. Drugs, 36, 728-730 (2005).
21. Zhou J., Xu X., Liu J. J., Lin Y. X., Gao G. D., Clin. Exp. Pharmacol. Physiol., 34, 1191-1198 (2007).
22. Van der Ploeg J. R., Giertsen E., Lüdin B., Mörgeli C., Zinkernagel A. S., Gmür R., FEMS Microbiol. Lett., 232, 31-37 (2004).
23. Ceckova M., Libra A., Pavek P., Nachtigal P., Brabec M., Fuchs R., Staud F., Clin. Exp. Pharmacol. Physiol., 33, 58-65 (2006).
24. Collins T., Cybulsky M. I., J. Clin. Invest., 107, 255-264 (2001).
25. Shanmugam N., Reddy M. A., Guha M., Natarajan R., Diabetes, 525, 1256-1264 (2003).
26. Glass C. K., Witztum J. L., Cell, 104, 503-516 (2001).
27. Libby P., Ridker P. M., Maseri A., Circulation, 105, 1135-1143 (2002).
28. Ridker P. M., Lancet, 358, 946-948 (2001).
29. Libby P., Simon D. I., Circulation, 103, 1718-1720 (2001).
30. Blake G. J, Ridker P. M., Circ. Res., 89, 763-771 (2001).
31. Bro S., Flyvbjerg A., Binder C. J., Bang C. A., Denner L., Olgaard K., Nielsen L. B., Atherosclerosis, 201, 274-280 (2008).
32. Zhang Y. G., Zhang H. G., Zhang G. Y., Fan J. S., Li X. H., Liu Y. H., Clin. Exp. Pharmacol. Physiol., 35, 1238-1244 (2008).
33. Yanni A. E., Lab. Anim., 38, 246-256 (2004).
34. Duverger N., Kruth H., Emmanuel F., Caillaud J. M., Viglietta C., Castro G., Tailleux A., Fievet C., Fruchart J. C., Houdebine L. M., Denefle P., Circulation, 94, 713-717 (1996).
35. Deng X. M., Sun Z. W., Wang X. D., Andersson R., Surg. Res. Commun., 19, 45-57 (1997).
36. Lindema J., Burkhardt H., Dwenger A., J. Clin. Chem. Clin. Biochem., 25, 765-778 (1998).
37. Bisoendial R. J., Kastelein J. J., Stroes E. S., Atherosclerosis, 195, e10-e18 (2007).
38. Ridker P. M., Circulation, 103, 1813-1818 (2001).
39. Kuller L. H., Tracy R. P., Shaten J., Meilahn E. N., Am. J. Epidemiol., 144, 537-547 (1996).
40. Pepys M. B., Hirschfield G. M., Tennent G. A., Gallimore J. R., Kahan M. C., Bellotti V., Hawkins P. N., Myers R. M., Smith M. D., Polara A., Cobb A. J., Ley S. V., Aquilina J. A., Robinson C. V., Sharif I., Gray G. A., Sabin C. A., Jenvey M. C., Kolstoe S. E., Thompson D., Wood S. P., Nature (London), 440, 1217-1221 (2006).
41. Jialal I., Devaraj S., Venugopal S. K., Hypertension, 44, 6-11 (2004).
42. Libby P., Nature (London), 420, 868-874 (2002).
43. Cuzzocrea S., Zingarelli B., Caputi A. P., Life Sci., 63, 923-933 (1998).
44. Jia Y., Li X. H., Acta Acad. Med. Militaris Tertiae, 27, 972-974 (2005).
45. Chen S. W., Li X. H., Ye K. H., Jiang Z. F., Ren X. D., Acta Pharmacol. Sin., 25, 1151-1156 (2004).
46. Lin S. G., Zheng X. L., Chen Q. Y., Sun J. J., Acta Pharmacol. Sin., 14, 314-316 (1993).
47. Harrington J. R., J. Clin. Invest., 105, 293-300 (2000).
48. Tanaka E., Shimokawa H., Kamiuneten H., Matsumoto Y., Morishige K., Koike G., Yoshinaga M., Egashira K., Tokunaga O., Shiomi M., Takeshita A., Arterioscler. Thromb. Vasc. Biol., 23, 244-250 (2003).
49. Hemmerich S., Paavola C., Bloom A., Bhakta S., Freedman R., Grunberger D., Krstenansky J., Lee S., McCarley D., Mulkins M., Wong B., Pease J., Mizoue L., Mirzadegan T., Polsky I., Thompson K., Handel T. M., Jarnagin K., Biochemistry, 38, 13013-13025 (1999).
50. Salcedo R., Ponce M. L., Young H. A., Wasserman K., Ward J. M., Kleinman H. K., Oppenheim J. J., Murphy W. J., Blood, 96, 34-40 (2000).
51. Stein O., Dabach Y., Ben-Naim M., Halperin G., Charo I. F., Stein Y., Biochem. Biophys. Res. Commun., 300, 477-481 (2003).
52. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C. H., Young S. G., Rollins B. J., Charo I. F., Clin. Invest., 103, 773-778 (1999).
53. Boisvert W. A., Trends Cardiovasc. Med., 14, 161-165 (2004).
54. Domoto K., Taniguchi T., Takaishi H., Takahashi T., Fujioka Y., Taka-hashi A., Ishikawa Y., Yokoyama M., Atherosclerosis, 171, 193-200 (2003).
55. Baeuerle P.A, Baltimore D., Cell, 87, 13-20 (1996).
56. Barnes P. J., Karin M., N. Engl. J. Med., 336, 1066-1071 (1997).
57. Navab M., Fogelman A. M., Berliner J. A., Territo M. C., Demer L. L., Frank J. S., Watson A. D., Edwards P. A., Lusis A. J., Am. J. Cardiol., 76, 18-23 (1995).
58. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P. A., Neumeier D., J. Clin. Invest., 97, 1715-1722 (1996).
59. Lindner V., Collins T., Am. J. Pathol., 148, 427-438 (1996).
60. Marumo T., Schin-Kerth V. B., Fisslthaler B., Busse R., Circulation, 96, 2361-2367 (1997).
61. Hotamisligil G. S., Nature (London), 444, 860-867 (2006).
62. Khovidhunkit W., Kim M. S., Memon R. A., Shigenaga J. K., Moser A. H., Feingold K. R., Grunfeld C., J. Lipid Res., 45, 1169-1196 (2004).
63. Liu Y., Xie M. X., Kang J., Zheng D., Spectrochim. Acta A, Mol. Biomol. Spectrosc., 59, 2747-2758 (2003).